Results 171 to 180 of about 644,115 (313)

EXPRESSION OF NOVEL ANTICOAGULANT FUSION PROTEINS INHIBITS FACTOR XA- AND THROMBIN-INDUCED ACTIVATION OF PORCINE VASCULAR ENDOTHELIAL CELLS.

open access: bronze, 2000
Daxin Chen   +6 more
openalex   +1 more source

Clinical utility of rivaroxaban in stroke prevention associated with nonvalvular atrial fibrillation – patient considerations

open access: yesJournal of Blood Medicine, 2014
Ingo Ahrens, Christoph Bode Heart Center, University of Freiburg, Department of Cardiology and Angiology I, Freiburg, Germany Abstract: The direct factor Xa inhibitor rivaroxaban was the first within the group of orally available direct factor Xa ...
Ahrens I, Bode C
doaj  

In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban [PDF]

open access: bronze, 2007
Grigoris Gerotziafas   +4 more
openalex   +1 more source

The 5 most frequently asked questions about factor Xa inhibitors. [PDF]

open access: yesHematology Am Soc Hematol Educ Program, 2022
Wang TF, Carrier M.
europepmc   +1 more source

tPA, but not uPA, Significantly Affects Antithrombotic Therapy by a Glycoprotein IIb/IIIa Antagonist, but not by a Factor Xa Inhibitor

open access: bronze, 2000
Motoi Nishida   +6 more
openalex   +1 more source

Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors?

open access: yesClinical Orthopaedics and Related Research, 2017
Abiram Bala   +4 more
semanticscholar   +1 more source

Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism. [PDF]

open access: yesCochrane Database Syst Rev, 2023
Li M   +11 more
europepmc   +1 more source

Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies [PDF]

open access: bronze, 2008
Pancras C. Wong   +7 more
openalex   +1 more source

Home - About - Disclaimer - Privacy